Fri, Sep 19, 2014, 1:22 PM EDT - U.S. Markets close in 2 hrs 38 mins

Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

thesavvymonkey777 661 posts  |  Last Activity: Dec 20, 2013 6:19 AM Member since: Mar 3, 2005
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • thesavvymonkey777 thesavvymonkey777 Dec 20, 2013 6:19 AM Flag

    Not even butt jokes can help you now. :-)

    Sentiment: Strong Sell

  • thesavvymonkey777 thesavvymonkey777 Dec 20, 2013 6:18 AM Flag

    Sure, and yet the fact remains that $181.75 is still the all time high for SPY, even with all of the bullish sentiment on Wall Street right now. Why can't this fat, bloated pig go any higher than that? OINK!

    Go ahead and buy some more shares of SPY up here at these high levels. What could possibly go wrong, right?

    Sentiment: Strong Sell

  • Pump harder! Hahahahaha!

    Sentiment: Strong Sell

  • thesavvymonkey777 thesavvymonkey777 Dec 20, 2013 5:28 AM Flag

    Eat crow? No, thank you. Monkeys prefer to eat bananas and homemade pot roast. Hee hee...

    Sentiment: Strong Buy

  • thesavvymonkey777 thesavvymonkey777 Dec 19, 2013 6:39 PM Flag

    Well, we're having an awful hard time getting there during an extremely jubilant time on Wall Street. What does that tell you?

    $181.75 is the all time high in SPY, and in my firm opinion, it's going to stay that way for a long, long, long time.

    Meanwhile, TTWO continues its steady run up the hill. Life is good.

    Sentiment: Strong Buy

  • thesavvymonkey777 by thesavvymonkey777 Dec 18, 2013 7:34 PM Flag

    I just had to return and poke fun at this fat, bloated pig. All of that stock market pumping today, and SPY STILL couldn't break through its all time high of $181.75/share... LOL!

    I called the all time high here right when it happened, and I'm standing by my prediction. :-)

    Sentiment: Strong Sell

  • thesavvymonkey777 thesavvymonkey777 Dec 18, 2013 7:32 PM Flag

    Don't worry, Tim. It won't get there. :-)

    $181.75/share is the 52 week high for SPY. That statement will end up holding quite true for the next 52 weeks in addition to the previous 52 weeks... IMO.

    Sentiment: Strong Buy

  • My monkey sense is tingling like crazy!

    Bernanke is going to screw the pooch tomorrow, and we're going to be dancing in the streets for a long time after that... IMO!

    Sentiment: Strong Buy

  • ...I've basically forgotten that it's a stock that can be traded. LOL.

    I just see it in my portfolio, and it's almost like wallpaper. It doesn't change at all... It just stays the same. Hahahaha!

    Whatever. Bring on The Binary Event. I'm waiting patiently for it, and this lack of action makes me want to ride this out to the ultimate crapshoot even more than I did earlier. AFFY is untradeable for almost everyone right now, and that's fine with me.

    Sentiment: Strong Buy

  • thesavvymonkey777 thesavvymonkey777 Dec 17, 2013 7:04 PM Flag

    Hahahaha! Yeah, my crystal ball does pretty good for me sometimes, I guess.

    Tomorrow's stock to watch is SDS. Bernanke is going to make me a very happy monkey tomorrow, indeed... IMO. :-)

    Sentiment: Strong Buy

  • My money is on SDS. :-)

    AFFY is just... Well, you know. It's AFFY.

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 5:55 PM Flag

    Agreed. It seems logical to me that the product would come back to the market, too. I'm willing to wait this out as long as it takes either way. At this point, I've honestly written off the ~$30K that I have invested here so far. If I lose all of it because The Binary Event doesn't go the way that I want it to go, then life goes on. It's a risk that I was willing to take based on MONTHS of due diligence that I did on the story of OMONTYS, and I'll just leave it at that. I won't torture myself if this story ends badly for me. Life is about taking risks here and there, and this is one of those situations for me.

    I'm looking at it this way... I'm risking the cost of a mid-size car in 2013 for a reward that could be the cost of a mid-size mansion in 2014. :-)

    Sentiment: Strong Buy

  • How many people out there do you suppose are going to have "weight loss" listed as a goal for 2014? If only there was a proven product out there that could help them to achieve their goals... :-)

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 4:55 PM Flag

    Correction... 17 months, not 16 months. :-)

    I would expect this story of the voluntary recall of OMONTYS to be wrapped up in early-to-mid 2014, be it good news for longs or bad news for longs... Place your bets and roll the bones!

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 4:52 PM Flag

    Looks like it took BIIB and ELN 16 months from the voluntary withdrawal to the FDA's re-approval... i.e. February 2005 to June 2006 per the blurb below taken from Wikipedia's information on TYSABRI.

    "Natalizumab was originally approved for treatment of multiple sclerosis in 2004, through the FDA's accelerated Fast Track program, due to the drug's efficacy in one-year clinical trials. In February 2005, four months after its approval, natalizumab was withdrawn voluntarily by the manufacturer after two cases of progressive multifocal leukoencephalopathy. Groups representing individuals with MS lobbied to have the drug returned to the US market and in June, 2006, after recommendation by an advisory committee and a review of two years of safety and efficacy data, the FDA re-approved natalizumab for patients with all relapsing forms of MS (relapse-remitting, secondary-progressive, and progressive-relapsing) as a first-line or second-line therapy. Patients taking natalizumab must enter into a registry for monitoring."

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 4:49 PM Flag

    Nope. I'm wrong. TYSABRI was a voluntary recall, too. I just looked it up on Wikipedia. :-)

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 2:38 PM Flag

    Wasn't ELN's TYSABRI removed from the market due to an involuntary recall? That would take more time to resolve with the FDA, I would assume... I was in ELN when it was $3.00/share, and I don't remember it as being a voluntary recall. I would research it and confirm my suspicions, but I'm watching a football game on TV right now. :-)

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 11:04 AM Flag

    Here's what American Regent has for VENOFER to warn future patients of the risks inherent in it. Copied directly from the VENOFER website...

    "IMPORTANT SAFETY INFORMATION

    Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Venofer (iron sucrose injection, USP). Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. If hypersensitivity reactions or signs of intolerance occur during administration, stop Venofer immediately. Monitor patients for signs and symptoms of hypersensitivity during and after Venofer administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Venofer when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions."

    Sounds like something Takeda could do for OMONTYS, doesn't it?

    Enough is enough. Get the product back out in the market, Takeda. Stop being paralyzed with things like root cause analysis and take action to make the world a better place going forward from here. You're depriving the many of the benefit of OMONTYS because of what happened to the few. Is that really the right thing to do?

    Sentiment: Strong Buy

  • Reply to

    Dear Takeda,

    by thesavvymonkey777 Dec 15, 2013 7:45 AM
    thesavvymonkey777 thesavvymonkey777 Dec 15, 2013 10:51 AM Flag

    I would be really curious as to what the longest time recorded has been in this industry for the announcement of a resolution of issues tied to a voluntary recall with the FDA. We have to be close to the upper time limits of "the others that have gone before us" at this point in time.

    It would be one thing if this was an involuntary recall, but it wasn't... It was VOLUNTARY on the part of AFFY and Takeda. I can understand the due diligence process, but at some point, enough is enough, because this entire timeline that Takeda is creating right now with the FDA is VOLUNTARY. The FDA isn't dictating it. So... Revise the labeling to warn about the risks inherent in the product, and then re-release it. This is what American Regent did with VENOFER... This trail has been blazed already! Issue warnings. Inform future patients of the risks. Test future patients for anaphylactic shock issues tied to the product before you give them the product. If Takeda can't exactly identify what caused the issues that a small handful of patients had with the product in the past, then so be it. Warn about it, test patients for it before using the product on them, and then move on.

    Taking away the rewards to the very many, because of the risks to the very few, is insanity at its highest level. I'm hoping that Takeda figures this out eventually.

    Sentiment: Strong Buy

  • ...and from there, it ran up to more than $70.00/share in 2011. Don't take my word for it, though... Check it out for yourself on a chart of the stock. I'd recommend using a large 10 year chart on Google Finance to plot it out so that you can see how fast this stock can take off when it crawls out of a hole. It could be hard to catch this bottle rocket when it shoots up into the stratosphere, as you can see.

    Chew on that... From $25.00/share to $70.00/share in roughly 3 years. Not too shabby at all. I can definitely handle those types of returns in a stock.

    So, here we are again in 2013, at less than $25.00/share, on the brink of what I think will be a significant pullback in the broad markets such as the S&P 500 to reality-based levels. Gold stocks such as NEM were traditionally a safe haven in the past during these types of economic scenarios. Where do we go now, Sweet Child O' Mine?

    Sentiment: Strong Buy

AFFY
0.160.00(+1.27%)1:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.